OpenLegislation

Regulation 2 Amendments to Part 1 of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020I1

England and Wales

(1)

Part 1 of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020f1 is amended as follows.

(2)

In regulation F12(1) (interpretation), in the appropriate places insert—

  • ““cluster” (“clwstwr”) means a group of local service providers involved in health and care who have agreed to collaboratively work together to deliver primary medical services across a specified geographical area;”;

  • ““Electronic Prescription Service” (“Gwasanaeth Presgripsiynau Electronig”) means the service of that name which is managed by Digital Health and Care Wales;”;

  • ““ophthalmic listed medicine” (“meddyginiaeth restredig offthalmig”) means a drug on the list of preparations approved by the Welsh Ministers which may be ordered by a qualifying optometrist for national health service primary ophthalmic services patients;”;

  • ““ophthalmic listed appliance” (“cyfarpar rhestredig offthalmig”) means an appliance on the list of preparations approved by the Welsh Ministers which may be ordered by a qualifying optometrist for national health service primary ophthalmic services patients;”;

  • ““Ophthalmic Combined List” (“Rhestr Gyfunol Offthalmig”) means the list required to be prepared by Local Health Boards by virtue of regulation 10 of the National Health Service (Ophthalmic Services) (Wales) Regulations 2023f2;”;

  • ““optometrist” (“optometrydd”) means a person registered as an optometrist in the register maintained under section 7 of the Opticians Act 1989f3 (register of opticians);”;

  • ““Primary Ophthalmic Services” (“Gwasanaethau Offthalmig Sylfaenol”) has the meaning given in regulation 4 of the National Health Service (Ophthalmic Services) (Wales) Regulations 2023;”;

  • ““qualifying optometrist” (“optometrydd cymhwysol”) means a person who is an optometrist included on a Local Health Board’s Ophthalmic Combined List who is providing or assisting in the provision of primary ophthalmic services in Wales;”.

(3)

In the definition of “prescriber”, in the first place it occurs, omit “pharmacist independent prescriber,”.

Annotations

Textual amendments

F1

Word in reg. 2(2) substituted (31.3.2025) by The National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/285), regs. 1(2), 3(2)

Commencement

I1

Reg. 2 in force at 1.4.2025, see reg. 1(4)

Footnotes

f1

S.I. 2020/1073 (W. 241).

f2

S.I. 2023/1053 (W. 179).

f3

1989 c. 44.